Oriplantee Company Limited
1 clinical trials · Sponsor
◉ Watch Oriplantee Company Limited
| Record | Firm | Date |
|---|---|---|
| A Phase I, Single-arm, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers (NCT07300202) | Oriplantee Company Limited | 2025-02-13 |
Track Oriplantee Company Limited automatically
Every clearance here is in the API, with alerts when new ones post.